What is the recommended HGH 191AA dosage?

HGH 191AA dosing varies by experience level. Beginners typically start at 667mcg daily, moderate users at 1333mcg daily, and aggressive protocols use 2000mcg daily.

How do you reconstitute HGH 191AA?

HGH 191AA typically comes in 3.3mg or 5mg vials. Add 1mL of bacteriostatic water to the vial. Use our free calculator for exact syringe units based on your desired dose.

What is the half-life of HGH 191AA?

The half-life of HGH 191AA is ~3-4 hours. This determines how frequently you need to dose for consistent blood levels.

HGH 191AA

Growth HormoneInjectionFDA ApprovedGrade A~3-4 hours half-life

Growth HormoneHGHSomatropinAnti-AgingMuscle GrowthFat Loss

Benefits

Direct GH elevation — most reliable method

Builds lean muscle and burns fat

Improves skin quality and elasticity

Enhances sleep depth and recovery

Supports bone density and joint health

Half-Life

~3-4 hours

Route

Injection

Frequency

Daily

Vial Sizes

3.3mg, 5mg

BAC Water

1mL

Safety Grade

Grade A

Open HGH 191AA Dosage Calculator

Calculate exact syringe units for your vial and dose

About HGH 191AA

HGH 191AA is synthetic human growth hormone (somatropin), identical to the 191-amino-acid protein produced by the pituitary gland. Unlike secretagogues that stimulate your body to release GH, this IS growth hormone — providing direct, reliable elevation. It's the gold standard for anti-aging, muscle building, fat loss, and recovery. Vials are measured in IU (international units): 1 IU ≈ 333mcg.

Who Should Consider HGH 191AA

Adults with diagnosed growth hormone deficiency (GHD) seeking replacement therapy
Athletes and bodybuilders aiming for accelerated muscle growth and fat loss
Older adults experiencing age-related GH decline affecting sleep, skin, and recovery
Individuals recovering from surgery, injury, or burns requiring enhanced tissue repair
Adults seeking body recomposition with direct, predictable GH elevation

What to Expect

Weeks 1-2

Improved sleep depth and onset. Mild water retention and joint stiffness possible as the body adjusts. No visible body composition changes yet.

Weeks 3-4

Energy and recovery noticeably improved. Skin begins to feel smoother and more hydrated. Mild carpal tunnel symptoms may appear at higher doses.

Weeks 5-8

Fat loss becomes visible, especially around the midsection. Lean muscle fullness increases. Workout recovery time shortens. Nail and hair growth may accelerate.

Weeks 9-16

Peak body composition changes. Skin elasticity and tone markedly improved. Joint comfort often improves despite initial stiffness. IGF-1 levels stabilize at an elevated baseline.

Weeks 16-24+

Long-term benefits in connective tissue repair, bone density, and immune function. Results are dose-dependent. Periodic blood work (IGF-1, fasting glucose) is recommended.

Dosing Protocol

Level	Dose / Injection	Frequency
Beginner	667mcg	Daily
Moderate	1,333mcg	Daily
Aggressive	2mg	Daily

Note: Synthetic human growth hormone (somatropin). 1 IU ≈ 333mcg. Vials labeled 10 IU ≈ 3.3mg, 15 IU ≈ 5mg. Beginner = 2 IU, Moderate = 4 IU, Aggressive = 6 IU. Store reconstituted vial refrigerated.

Pharmacokinetics

Half-Life

3.5h

Bioavailability

SC: ~70-80%; IV: 100% (reference)

Tmax

3-5 hours (SC)

Data Confidence

high

Source: SC terminal half-life from PK studies in healthy volunteers (PMID 11505794)

Pharmacokinetics — Active Dose Over Time

Loading the interactive decay curve.

Side Effects

Water retention, joint pain, carpal tunnel syndrome, increased blood sugar. Long-term use requires monitoring IGF-1 levels. Start low and titrate.

Contraindications

Active malignancy or history of cancer — GH can promote tumor growth via IGF-1
Proliferative or severe non-proliferative diabetic retinopathy
Acute critical illness due to surgery, trauma, or respiratory failure
Prader-Willi syndrome with severe obesity or respiratory impairment
Known hypersensitivity to somatropin, excipients, or metacresol preservative
Closed epiphyses in children when used for linear growth — no further height benefit
Pregnancy or breastfeeding — insufficient safety data

Drug Interactions

Glucocorticoids (prednisone, hydrocortisone) — may reduce GH efficacy; GH may also unmask adrenal insufficiency
Insulin and oral hypoglycemics — GH raises blood glucose; diabetes medication doses may need adjustment
Thyroid hormones — GH can increase conversion of T4 to T3; monitor thyroid function and adjust levothyroxine if needed
CYP450-metabolized drugs (e.g., cyclosporine, sex steroids, anticonvulsants) — GH may alter clearance of these medications
Estrogen (oral) — oral estrogen reduces GH response; transdermal estrogen has less impact